Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Hawthorn leaf contains bioactive flavonoids—quercetin, kaempferol, isorhamnetin, and oligomeric proanthocyanidins—that provide cardiovascular protection by suppressing pro-inflammatory cytokines (IL-6, IL-1β, TNF-α), inhibiting the SCAP-SREBP2-LDLR cholesterol pathway via sPLA2-IIA signaling in macrophages, and modulating gut microbiota to reduce lipid accumulation (PMID 38442806; PMID 40161310). A 2024 study in the Journal of Ethnopharmacology demonstrated that hawthorn leaf flavonoids significantly alleviated atherosclerosis progression in mice by downregulating SCAP-SREBP2 pathway proteins and reducing macrophage-derived foam cell formation, while a 2025 study in Current Research in Food Science confirmed that hawthorn leaf extract reduced high-fat-diet-induced obesity and reshaped gut microbiome composition in murine models.
Reported Benefits (Provisional)
Origin & History
Hawthorn Leaf (*Crataegus* species) is derived from deciduous shrubs and trees native to temperate regions of Europe, Asia, and North America. Revered for its cardioprotective properties, it is a cornerstone botanical in functional nutrition for supporting cardiovascular wellness and emotional balance.
Research Narrative (Provisional)
Bai et al. (2024) published in the Journal of Ethnopharmacology (PMID 38442806) demonstrated that hawthorn leaf flavonoids alleviate atherosclerosis in mice by inhibiting the SCAP-SREBP2-LDLR pathway through sPLA2-IIA signaling in macrophages, reducing foam cell formation and arterial plaque burden. Liu Z et al. (2025) in Current Research in Food Science (PMID 40161310) showed that hawthorn leaf and its extract significantly reduced body weight, visceral fat, and serum lipids in high-fat-diet mice while positively modulating gut microbiome diversity. A comprehensive ethnopharmacological review by Li R et al. (2023) in the Journal of Ethnopharmacology (PMID 36228891) catalogued over 150 phytochemicals in Crataegus pinnatifida—including flavonoids, triterpenoids, and organic acids—and summarized evidence for cardioprotective, anti-inflammatory, hypolipidemic, and antioxidant activities. Huiming HU et al. (2025) in the Journal of Traditional Chinese Medicine (PMID 40151127) used network pharmacology to confirm the hypolipidemic mechanism of hawthorn-containing Hedan tablets, identifying key targets including PPARG, PTGS2, and TNF pathways.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Flavonoids (quercetin, rutin), Oligomeric Proanthocyanidins (OPCs), Triterpenoids, Phenolic acids. - Vitamins: Vitamin C. - Minerals: Potassium, Calcium, Magnesium. - Macronutrients: Dietary fiber.
Reported Mechanism (Provisional)
Hawthorn leaf flavonoids—principally quercetin, kaempferol, and isorhamnetin—exert cardiovascular protection by inhibiting the SCAP-SREBP2-LDLR cholesterol biosynthesis pathway via suppression of secretory phospholipase A2 group IIA (sPLA2-IIA) signaling in macrophages, thereby reducing intracellular lipid accumulation and foam cell formation critical to atherosclerotic plaque development (PMID 38442806). These compounds simultaneously suppress pro-inflammatory mediators including cyclooxygenase-2 (PTGS2), matrix metalloproteinases MMP2 and MMP9, and cytokines IL-6, IL-1β, and TNF-α, while activating peroxisome proliferator-activated receptor alpha (PPAR-α) nuclear receptors to enhance hepatic fatty acid β-oxidation and triglyceride clearance (PMID 40151127). Oligomeric proanthocyanidins (OPCs) and procyanidin B2—abundant in hawthorn leaf—scavenge reactive oxygen species, upregulate endothelial nitric oxide synthase (eNOS) to promote vasodilation, and inhibit NF-κB-mediated inflammatory gene transcription (PMID 37059021). Additionally, hawthorn leaf polyphenols modulate gut microbiota composition by increasing beneficial Lactobacillus and Akkermansia populations while reducing Firmicutes-to-Bacteroidetes ratios, improving systemic metabolic homeostasis through the microbiota-gut-liver axis (PMID 40161310; PMID 40086971).
Clinical Narrative (Provisional)
Current evidence for hawthorn leaf primarily comes from network pharmacology studies and animal models rather than robust human clinical trials. In animal studies, hawthorn leaf flavonoids at 50-200 mg/kg doses for 16 weeks significantly increased SOD activity and decreased MDA levels in diabetic cardiomyopathy models. Cellular studies demonstrate that quercetin, kaempferol, and isorhamnetin inhibit LPS-induced macrophage viability and inflammatory gene expression. Quantitative human clinical trial data with specific patient outcomes and effect sizes is currently lacking in the available research.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.